Work

Abstract 1573: MW-C1, a novel CLDN1-targeting ADC demonstrates compelling anti-tumor efficacy and favorable safety profile in preclinical studies

Year: 2025
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4409640925
Cites:
Cited by:
Related to: 10